Clinical and immunological benefit of adjuvant therapy with thalidomide in the treatment of tuberculosis disease

AIDS

Volumn 14, Issue 12, 2000, Pages 1859-1861

  Gori, Andrea ^a   Rossi, Maria Cristina ^a   Marchetti, Giulia ^a   Trabattoni, Daria ^a   Molteni, Chiara ^a   Cogliati, Marta ^a   Bandera, Alessandra ^a   Clerici, Mario ^a   Franzetti, Fabio ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CIPROFLOXACIN; CLARITHROMYCIN; CYTOKINE; EFAVIRENZ; ETHAMBUTOL; GAMMA INTERFERON; INDINAVIR; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; ISONIAZID; LAMIVUDINE; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; STAVUDINE; STREPTOMYCIN; THALIDOMIDE; TUBERCULOSTATIC AGENT; VIRUS RNA; ZIDOVUDINE;

ADJUVANT CHEMOTHERAPY; ADULT; ANOREXIA; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EDEMA; FEMALE; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTENSION; LYMPHOCYTE COUNT; MALE; MYCOBACTERIUM TUBERCULOSIS; NAUSEA; PARESTHESIA; PRIORITY JOURNAL; PRURITUS; RASH; TUBERCULOSIS; VIRUS LOAD; WEIGHT GAIN;

ADULT; ANTITUBERCULAR AGENTS; CD4 LYMPHOCYTE COUNT; CYTOKINES; FEMALE; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; THALIDOMIDE; TIME FACTORS; TUBERCULOSIS; VIRAL LOAD;

EID: 0033831351     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200008180-00026     Document Type: Article

References (5)

1. Thalidomide in toxic epidermal necrolysis
2. Thalidomide selectively inhibits tumor necrosis factor α production by stimulated human monocytes
3. Thalidomide as an anti-TNF-alpha inhibitor: Implications for clinical use
4. Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis
5. Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection